Concepedia

Anneliese Schneider

AS

13

Publications

908

Citations

13

H-Index

1996

Active since

Affiliations

Roche (Switzerland)(Current)

University of Tübingen

University of Basel

Technical University of Munich

Roche Pharma AG (Germany)

Anneliese Schneider is an author at Roche (Switzerland) specializing in medicine, radiation oncology, and tumor biology.

Top concepts

Publications per year

1996–2023

13

Publications

13

The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

Peter Brossart, Anneliese Schneider, Patricia Dill et al. · PubMed · 2001 · 201 citations

, , +18

Transforming growth factor‐beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer

Karl‐Hermann Schlingensiepen, Frank Jaschinski, Sven Arke Lang et al. · Cancer Science · 2011 · 139 citations · Full text

Stable Expression of Human Cytochrome P450 1B1 in V79 Chinese Hamster Cells and Metabolically Catalyzed DNA Adduct Formation of Dibenzo[<i>a</i>,<i>l</i>]pyrene

Andreas Luch, Stephanie L. Coffing, Yong Tang et al. · Chemical Research in Toxicology · 1998 · 111 citations

Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies

S. Jordan Kerns, Chaitra Belgur, Debora B. Petropolis et al. · eLife · 2021 · 69 citations · Full text

, , +17

Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids

Marius F. Harter, Timothy Recaldin, Régine Gérard et al. · Nature Biomedical Engineering · 2023 · 62 citations · Full text

Rows per page

1–5 of 13